Global Radiation Oncology Market 2017-2021

放射線腫瘍学の世界市場:EBRT、小線源治療

◆タイトル:Global Radiation Oncology Market 2017-2021
◆商品コード:IRTNTR14710
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年9月28日
◆ページ数:97
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥374,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavioが発行した当調査レポートでは、放射線腫瘍学の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、放射線腫瘍学の世界市場規模及び予測、製品別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は放射線腫瘍学の世界市場が2017-2021年期間中に年平均5.29%成長すると予測しています。当レポート上に記載されている主な企業は、Accuray、C. R. Bard、Elekta、IBA Worldwide、Varian Medical Systems等です。

About Radiation Oncology
Radiation treatment, which is also called radiotherapy, irradiation, or X-ray therapy, is one of the most common treatments for cancer. It uses high-energy particles or waves such as X-rays, gamma rays, electron beams, or protons to destroy or damage cancer cells. More than half of all people with cancer are treated with radiation therapy. Radiation therapy can be administered through EBRT or brachytherapy. EBRT delivers high-energy rays or beams from outside the body into the tumor. The beams are generated outside the patient, generally by a linear accelerator (LINAC), and targeted at the tumor site.

Technavio’s analysts forecast the global radiation oncology market to grow at a CAGR of 5.29% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global radiation oncology market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Radiation Oncology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Accuray
• C. R. Bard
• Elekta
• IBA Worldwide
• Varian Medical Systems

[Other prominent vendors]
• Carl Zeiss Meditec
• iCAD
• IsoRay
• Mevion Medical Systems
• Nordion
• NTP Radioisotopes
• Toshiba Medical Systems

[Market driver]
• Increasing incidence of cancer
• For a full, detailed list, view our report

[Market challenge]
• Lack of access to radiotherapy
• For a full, detailed list, view our report

[Market trend]
• Strategic collaborations and M&A
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Overview
• Market size and forecast
• Five forces analysis

PART 06: Segmentation by product type
• Overview
• EBRT
• Brachytherapy

PART 07: Segmentation by geography
• Overview
• Americas
• EMEA
• APAC

PART 08: Decision framework

PART 09: Drivers and challenges
• Market drivers
• Market challenges

PART 10: Market trends
• Strategic collaborations and M&A
• Increasing demand for proton therapy

PART 11: Vendor landscape
• Competitive landscape

PART 12: Key vendor analysis
• Accuray
• C. R. Bard
• Elekta
• IBA Worldwide
• Varian Medical Systems
• Other prominent vendors

PART 13: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Global radiation oncology market: Segmentation
Exhibit 02: Global radiation oncology market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global radiation oncology market: Segmentation by product type 2016 (% share)
Exhibit 05: Global EBRT market 2016-2021 ($ millions)
Exhibit 06: Global EBRT market: Segmentation by product type
Exhibit 07: Major LINACs
Exhibit 08: Global LINAC market 2016-2021 ($ millions)
Exhibit 09: Major compact advanced radiotherapy systems
Exhibit 10: Global compact advanced radiotherapy systems market 2016-2021 ($ millions)
Exhibit 11: Global compact advanced radiotherapy systems market: Segmentation by product type 2016 (% share)
Exhibit 12: Major proton therapy systems
Exhibit 13: Global proton therapy systems market 2016-2021 ($ millions)
Exhibit 14: Global brachytherapy market 2016-2021 ($ millions)
Exhibit 15: Major brachytherapy seeds, applicators, and after loaders
Exhibit 16: Global brachytherapy seeds, applicators, and after loaders market 2016-2021 ($ millions)
Exhibit 17: Major electronic brachytherapy systems
Exhibit 18: Global electronic brachytherapy market 2016-2021 ($ millions)
Exhibit 19: Global radiation oncology market: Segmentation by geography 2016 (% share)
Exhibit 20: Radiation oncology market in Americas 2016-2021 ($ millions)
Exhibit 21: Radiation oncology market in EMEA 2016-2021 ($ millions)
Exhibit 22: Radiation oncology market in APAC 2016-2021 ($ millions)
Exhibit 23: Radiotherapy equipment available per 1,000,000 people in healthcare facilities 2013 and 2015
Exhibit 24: Global radiation oncology market: Competitive structure analysis 2016
Exhibit 25: Accuray: Key highlights
Exhibit 26: Accuray: Strength assessment
Exhibit 27: Accuray: Strategy assessment
Exhibit 28: Accuray: Opportunity assessment
Exhibit 29: C. R. Bard: Key highlights
Exhibit 30: C. R. Bard: Strength assessment
Exhibit 31: C. R. Bard: Strategy assessment
Exhibit 32: C. R. Bard: Opportunity assessment
Exhibit 33: Elekta: Key highlights
Exhibit 34: Elekta: Strength assessment
Exhibit 35: Elekta: Strategy assessment
Exhibit 36: Elekta: Opportunity assessment
Exhibit 37: IBA Worldwide: Key highlights
Exhibit 38: IBA Worldwide: Strength assessment
Exhibit 39: IBA Worldwide: Strategy assessment
Exhibit 40: IBA Worldwide: Opportunity assessment
Exhibit 41: Varian Medical Systems: Key highlights
Exhibit 42: Varian Medical Systems: Strength assessment
Exhibit 43: Varian Medical Systems: Strategy assessment
Exhibit 44: Varian Medical Systems: Opportunity assessment



【掲載企業】

Accuray, C. R. Bard, Elekta, IBA Worldwide, Varian Medical Systems, Carl Zeiss Meditec, iCAD, IsoRay, Mevion Medical Systems, Nordion, NTP Radioisotopes, and Toshiba Medical Systems.


【資料のキーワード】

放射線腫瘍学、EBRT、小線源治療

★調査レポート[放射線腫瘍学の世界市場:EBRT、小線源治療] (Global Radiation Oncology Market 2017-2021 / IRTNTR14710)販売に関する免責事項
[放射線腫瘍学の世界市場:EBRT、小線源治療] (Global Radiation Oncology Market 2017-2021 / IRTNTR14710)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆